Our chief scientific officer, Rebecca Kush, spoke to Outsourcing-Pharma about our newly announced expanded System of Accelerated Research (SOAR®) technology model designed to support decentralized and hybrid clinical trials with remote monitoring capabilities. Click below to learn more about the conversation.
Article